Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Jan 20, 2021
Date Accepted: Feb 22, 2022

The final, peer-reviewed published version of this preprint can be found here:

Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice

Scheinker D, Gu A, Grossman J, Ward A, Ayerdi O, Miller D, Leverenz J, Hood K, Lee MY, Maahs DM, Prahalad P

Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice

JMIR Diabetes 2022;7(2):e27284

DOI: 10.2196/27284

PMID: 35666570

PMCID: 9210201

Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: A Prospective Evaluation in Clinical Practice

  • David Scheinker; 
  • Angela Gu; 
  • Josh Grossman; 
  • Andrew Ward; 
  • Oseas Ayerdi; 
  • Daniel Miller; 
  • Jeannine Leverenz; 
  • Korey Hood; 
  • Ming Yeh Lee; 
  • David M Maahs; 
  • Priya Prahalad

ABSTRACT

Background:

Continuous glucose monitors (CGM) are recommended as standard of care by the American Diabetes Association for individuals with type 1 diabetes on insulin. These devices generate glucose readings every 5-15 minutes and use cloud-based platforms to share data. This remotely reviewed data can be used by members of diabetes care team to provide remote care.

Objective:

To design an automated tool that facilitates timely, personalized, population-level guidance for glucose management through asynchronous telehealth.

Methods:

Using CGM data from six clinical trials and two observational datasets, we developed manufacturer-agnostic algorithms to generate generic (e.g., mean glucose (MG) > 170mg/dL) and personalized (e.g., MG increased by >10mg/dL) flags. We developed and deployed an automated tool in a pediatric type 1 diabetes clinic, measured sensitivity for identifying who may benefit from telehealth, and measured the time saved reviewing data with the use of the tool.

Results:

The eight cohorts contained 1,365 patients with 30,017 weeks of data collected by seven types of CGMs. In the cohort with the highest MG, 81.3% (26 of 32) and 3.1% (1/32) of people had a generic and personalized flag every week, respectively. In the clinic, on average, 57.2% of patients were flagged per week, corresponding to a sensitivity of 98.6% and a 42.8% reduction in the time required to review data.

Conclusions:

The automated analysis of CGM data may help identify people requiring guidance on glucose management while reducing the workload for care providers. The rules-based approach provided fully interpretable representations of patient status relative to the latest guidelines. When deployed in a clinic, an automated tool to generate flags identified 98.6% of patients who would benefit from asynchronous telehealth contact while reducing the time required to review patient data by 42.8%. Guideline-based population health management may become more accessible through the use of automated tools.


 Citation

Please cite as:

Scheinker D, Gu A, Grossman J, Ward A, Ayerdi O, Miller D, Leverenz J, Hood K, Lee MY, Maahs DM, Prahalad P

Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice

JMIR Diabetes 2022;7(2):e27284

DOI: 10.2196/27284

PMID: 35666570

PMCID: 9210201

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.